The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Receipt and survival outcomes by age following second-line therapy for metastatic CRC (mCRC): Analysis of 5,289 patients from the ARCAD Clinical Trials Program.
 
Nadine Jackson McCleary
No Relationships to Disclose
 
William S. Harmsen
No Relationships to Disclose
 
Eric VanCutsem
No Relationships to Disclose
 
Alberto F. Sobrero
Stock and Other Ownership Interests - Bayer
Consulting or Advisory Role - Amgen; Bayer; Celgene; Menarini; Merck Serono; Roche; Sanofi; SERVIER
Speakers' Bureau - amgen; AstraZeneca; Bayer; Bristol-Myers Squibb; celgene; Lilly; Merck Serono; Roche; Sanofi; Takeda
Travel, Accommodations, Expenses - Bayer; Merck Serono; Roche; Takeda
 
Richard M. Goldberg
Honoraria - Amgen
Consulting or Advisory Role - Merck; Merck KGaA; Novartis; Taiho Pharmaceutical
Research Funding - Bristol-Myers Squibb
Travel, Accommodations, Expenses - Amgen; Merck; Merck KGaA
 
Josep Tabernero
Consulting or Advisory Role - Array BioPharma; AstraZeneca; Bayer; BeiGene; Biocartis; Boehringer Ingelheim; Chugai Pharma; Foundation Medicine; Genentech; Genmab; HalioDx; Halozyme; Imugene; Inflection Biosciences; Ipsen; Kura Oncology; Lilly; Menarini; Merck Serono; Merrimack; Merus; Molecular Partners; MSD; Novartis; Peptomyc; Pfizer; Pharmacyclics; ProteoDesign; Rafael Pharmaceuticals; Roche; Roche; Sanofi; Seagen; Seagen; Servier; Symphogen; Taiho Pharmaceutical; VCN Biosciences
 
Matt Seymour
No Relationships to Disclose
 
Leonard B. Saltz
Research Funding - Taiho Pharmaceutical
 
Bruce J. Giantonio
No Relationships to Disclose
 
Arnold Dirk
No Relationships to Disclose
 
Mace L. Rothenberg
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Miriam Koopman
Research Funding - Bayer (Inst); Merck Serono (Inst); Roche (Inst); Sanofi (Inst); Servier (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Hans-Joachim hans-joachim Schmoll
Honoraria - Amgen; Roche
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Roche
Research Funding - Amgen; Roche
Travel, Accommodations, Expenses - Amgen; Bayer; Roche
 
Henry C. Pitot
No Relationships to Disclose
 
Paulo Marcelo Hoff
Consulting or Advisory Role - Genzyme (I); United Health Group (I)
Research Funding - AstraZeneca/MedImmune (Inst); Bayer (Inst); Eisai (Inst); Exelixis (Inst); MSD Oncology (Inst); Novartis (Inst); Roche/Genentech (Inst)
 
Alfredo Falcone
Honoraria - Amgen; Lilly; Merck; Roche; SERVIER
Consulting or Advisory Role - Amgen; Bayer; Bristol-Myers Squibb; Lilly; Merck; Roche; SERVIER
Research Funding - Amgen (Inst); Bayer (Inst); Merck (Inst); MSD (Inst); Roche (Inst); Sanofi (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Roche; SERVIER
 
Aimery De Gramont
Honoraria - Chugai Pharma; Yakult Pharmaceutical
 
Qian Shi
No Relationships to Disclose
 
Stuart M. Lichtman
Consulting or Advisory Role - Magellan Health; Magellan Health; Remedy One; Remedy One; Remedy One; Remedy One